- Latest available (Revised)
- Original (As made)
There are currently no known outstanding effects for the The Human Tissue (Quality and Safety for Human Application) Regulations 2007, Section 20B.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
20B.—(1) Paragraph (2) applies where—
(a)qualifying tissues or cells are imported into [F3Northern Ireland] from a third country by an importing licence holder;
(b)the tissues or cells are distributed in an EEA stateF4...; and
(c)the competent authority in that state F5... (“the requesting authority”) requests the Authority to carry out any of the following activities—
(i)to arrange for an inspection of any third country premises to be carried out on behalf of the Authority;
(ii)to arrange for an inspection of any relevant documents held by a third country supplier to be carried out on behalf of the Authority;
(iii)to exercise the Authority’s power under paragraph 7(2) of Schedule 3 to the 2004 Act to revoke a licence held by an importing licence holder;
(iv)to exercise the Authority’s powers under paragraph 8(3) of Schedule 3 to the 2004 Act to vary a licence held by an importing licence holder; or
(v)other appropriate control measures.
(2) The Authority must carry out the activity in question specified in paragraph (1)(c), unless it considers that it would be inappropriate to do so in the particular circumstances of the case.
(3) Before an inspection of any premises is carried out pursuant to paragraph (2), the Authority must—
(a)make arrangements with the competent authority which made the request under paragraph (1) for that competent authority to participate in the inspection; or
(b)notify the competent authority which made the request under paragraph (1) that the Authority has decided that it is not appropriate for that competent authority to participate in the inspection and give reasons for that decision.
(4) For the purposes of ascertaining whether qualifying tissues or cells imported into [F6Northern Ireland] from a third country meet standards of quality and safety equivalent to those laid down in these Regulations, the Authority may arrange for either or both of the following to be carried out on its behalf—
(a)an inspection of any third country premises; or
(b)an inspection of any relevant document held by a third country supplier.
(5) The Authority may arrange for a report to be made on any inspection carried out in pursuance of paragraph (2) or (4).
(6) Any inspection carried out in pursuance of paragraphs (2) and (4) must be carried out by a person authorised by the Authority for the purposes of this regulation.
(7) An inspection of any premises made under this regulation must include, in particular—
(a)the inspection of any equipment found on the premises;
(b)the inspection and copying of any relevant documents or records found on the premises; and
(c)the observation of any activity relevant to ascertaining whether qualifying tissues or cells imported from a third country meet standards of quality and safety equivalent to those laid down in these Regulations.
(8) In this regulation—
“qualifying tissues or cells” means tissues or cells intended for human application;
“relevant documents” mean documents relevant for the purposes of ascertaining whether qualifying tissues or cells imported from a third country meet standards of quality and safety equivalent to those laid down in these Regulations;
“requesting authority” has the meaning given in paragraph (1)(c).]
Textual Amendments
F1Regs. 20A-20C inserted (6.3.2018 for specified purposes, 1.4.2018 in so far as not already in force) by The Human Tissue (Quality and Safety for Human Application) (Amendment) Regulations 2018 (S.I. 2018/335), regs. 1(2)(3), 5(2)
F2Words in reg. 20B heading inserted (31.12.2020) by The Human Tissue (Quality and Safety for Human Application) (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/481), regs. 1, 3(13)(a) (as substituted by S.I. 2020/1306, regs. 1, 17); 2020 c. 1, Sch. 5 para. 1(1)
F3Words in reg. 20B(1)(a) substituted (31.12.2020) by The Human Tissue (Quality and Safety for Human Application) (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/481), regs. 1, 3(13)(b) (as substituted by S.I. 2020/1306, regs. 1, 17); 2020 c. 1, Sch. 5 para. 1(1)
F4Words in reg. 20B(1)(b) omitted (31.12.2020) by virtue of The Human Tissue (Quality and Safety for Human Application) (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/481), regs. 1, 3(13)(c) (as substituted by S.I. 2020/1306, regs. 1, 17); 2020 c. 1, Sch. 5 para. 1(1)
F5Words in reg. 20B(1)(c) omitted (31.12.2020) by virtue of The Human Tissue (Quality and Safety for Human Application) (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/481), regs. 1, 3(13)(d) (as substituted by S.I. 2020/1306, regs. 1, 17); 2020 c. 1, Sch. 5 para. 1(1)
F6Words in reg. 20B(4) substituted (31.12.2020) by The Human Tissue (Quality and Safety for Human Application) (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/481), regs. 1, 3(13)(e) (as substituted by S.I. 2020/1306, regs. 1, 17); 2020 c. 1, Sch. 5 para. 1(1)
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: